发明公开
- 专利标题: RECOMBINANT C140 RECEPTOR AND ITS AGONISTS AND ANTAGONISTS
- 专利标题(中): 重组C140及其受体激动剂和拮抗剂
-
申请号: EP94925135申请日: 1994-07-26
-
公开(公告)号: EP0804452A4公开(公告)日: 1998-08-12
- 发明人: SCARBOROUGH ROBERT M , SUNDELIN JOHAN
- 申请人: COR THERAPEUTICS INC
- 专利权人: COR THERAPEUTICS INC
- 当前专利权人: COR THERAPEUTICS INC
- 优先权: US9793893 1993-07-26
- 主分类号: C12N15/09
- IPC分类号: C12N15/09 ; A61K38/00 ; A61K48/00 ; C07H21/04 ; C07K7/06 ; C07K7/08 ; C07K14/705 ; C07K14/72 ; C07K16/28 ; C12N5/10 ; C12P21/02 ; C12R1/91 ; C07H21/00 ; C07K2/00 ; C07K7/00
摘要:
The DNA encoding the C140 cell surface receptor has been cloned and sequenced. The availability of this DNA permits the recombinant production of the C140 receptor which can be produced at cell or oocyte surfaces and is useful in assay systems both for the detection of substances which affect its activity, including agonists and antagonists. Further, the elucidation of the structure of the C140 receptor permits the design of agonist and antagonist compounds which are useful in these assays. The availability of the C140 receptor also permits production of antibodies specifically immunoreactive with the receptor per se or with specific regions thereof.
信息查询
IPC分类: